VOYA Investment Management’s Olema Pharmaceuticals OLMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.81M Buy
121,494
+95,503
+367% +$2.13M ﹤0.01% 1231
2025
Q4
$650K Buy
25,991
+14,909
+135% +$265K ﹤0.01% 1638
2025
Q3
$108K Sell
11,082
-5,498
-33% -$33K ﹤0.01% 2288
2025
Q2
$70.6K Buy
16,580
+4,801
+41% +$21.4K ﹤0.01% 2550
2025
Q1
$44.3K Sell
11,779
-744
-6% -$3.74K ﹤0.01% 2564
2024
Q4
$73K Sell
12,523
-39,695
-76% -$396K ﹤0.01% 2640
2024
Q3
$623K Buy
52,218
+20,746
+66% +$265K ﹤0.01% 1884
2024
Q2
$341K Sell
31,472
-98,115
-76% -$1.06M ﹤0.01% 2199
2024
Q1
$1.47M Buy
129,587
+118,486
+1,067% +$1.53M ﹤0.01% 1466
2023
Q4
$156K Buy
11,101
+258
+2% +$3.47K ﹤0.01% 2649
2023
Q3
$134K Hold
10,843
﹤0.01% 2659
2023
Q2
$97.9K Buy
+10,843
New +$65.5K ﹤0.01% 2791
2021
Q4
Sell
-9,650
Closed -$266K 2810
2021
Q3
$266K Buy
+9,650
New +$260K ﹤0.01% 2404

Other funds holding OLMA

VOYA Investment Management's OLMA Position: Q1 2026 in Review

VOYA Investment Management increased its Olema Pharmaceuticals (OLMA) stake by 367% in Q1 2026, buying an estimated $2.13M and bringing the position to 121,494 shares worth $1.81M. The position accounts for ﹤0.01% of the portfolio, ranked #1231.

VOYA Investment Management first reported a position in OLMA in Q3 2021 and has held it in 13 quarters since. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • VOYA Investment Management held 121,494 shares of Olema Pharmaceuticals worth $1.81M as of Q1 2026.
  • VOYA Investment Management bought 95,503 Olema Pharmaceuticals shares in Q1 2026, an estimated $2.13M.
  • Olema Pharmaceuticals made up ﹤0.01% of VOYA Investment Management's portfolio in Q1 2026, its #1231 holding.
  • VOYA Investment Management first reported a position in Olema Pharmaceuticals in Q3 2021 and has held it in 13 quarters since.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.